Towarzystwo Funduszy Inwestycyjnych PZU SA’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Towarzystwo Funduszy Inwestycyjnych PZU SA's DGX Position: Q2 2026 in Review
Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Quest Diagnostics (DGX) stake by 67% in Q2 2026, buying an estimated $19.6K and bringing the position to 250 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #456.
Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Towarzystwo Funduszy Inwestycyjnych PZU SA held 250 shares of Quest Diagnostics worth $53K as of Q2 2026.
- Towarzystwo Funduszy Inwestycyjnych PZU SA bought 100 Quest Diagnostics shares in Q2 2026, an estimated $19.6K.
- Quest Diagnostics made up 0.01% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #456 holding.
- Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.